Addex Therapeutics (ADXN) vs Propanc Biopharma (PPCB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Addex Therapeutics is the larger company by market cap ($5.5 million vs $4.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | ADXN | PPCB |
|---|---|---|
| Share price | $3.13 | $0.4987 |
| Market cap | $5.49M | $4.90M |
| 1-day change | -0.32% | +1.51% |
| EPS (TTM) | $-7.56 | $-17.62 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $11.97 | $48.75 |
| 52-week low | $2.56 | $0.46 |
| Distance from 52-week high | -73.85% | -98.98% |
| Average volume | 138.01K | 1.79M |
| Shares outstanding | 1.75M | 9.83M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ADXN vs PPCB FAQ
Which is bigger, Addex Therapeutics or Propanc Biopharma?
Addex Therapeutics (ADXN) is larger, with a market capitalization of $5.49M compared with $4.90M for Propanc Biopharma (PPCB).
Are Addex Therapeutics and Propanc Biopharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.